Please login to the form below

Not currently logged in
Email:
Password:

FDA

This page shows the latest FDA news and features for those working in and with pharma, biotech and healthcare.

FDA approves expanded use of BMS’ Reblozyl in blood disorders

FDA approves expanded use of BMS’ Reblozyl in blood disorders

drug. The FDA has cleared Reblozyl (luspatercept) for anaemia in adults with lower-risk MDS with ring sideroblasts – an uncommon form of the cancer characterised by red blood cell with ... Reblozyl got the go-ahead from the FDA last November for

Latest news

More from news
Approximately 697 fully matching, plus 2,710 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 2 fully matching, plus 131 partially matching documents found.

Latest appointments

More from appointments
Approximately 6 fully matching, plus 43 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 45 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
JPA Health Communications

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics